ARCHIVES

“Sloppy Work” May Invalidate Methylene Chloride Study; Contractor Hints NTP Pressured By Industry

This article is from The Cancer Letter archive.

Vol. 09 No. 39 | October 14, 1983

Download PDF Visit The Full Archive

Related Articles

Sorafenib Targets AML Driven By Mutant FLT3 Gene

February 29, 2008

Fragmin Cuts Risk Of VE By 50 Percent In Study

January 31, 2003

Overdiagnosis Can Result In Harm To Patients, Experts Say.

November 3, 2006

In Brief: Peter Greenwald A Leading Candidate For One Of Three Top NCI Jobs Remaining To Be Filled

August 7, 1981

In Brief: Donald Metcalf Wins Bristol-Myers Award; NCI Starts Search for Biological Carcinogenesis AD

May 1, 1987

Bristol No Longer Needs Yew From Public Lands, Official Says; Will Use Processed Needles

January 29, 1993